n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Tuesday, May 24th, 2016

The QualityStocks
Daily Stock List

graphic
graphic

Northern Minerals & Exploration Ltd. (NMEX)

SmallCapVoice, TopPennyStockMovers, Club Penny Stocks Network, First Penny Picks, OTPicks, OTCBB Journal and Orbit Stocks reported earlier on Northern Minerals & Exploration Ltd. (NMEX) and we report on the Company today, here at the QualityStocks Daily Newsletter.

Northern Minerals & Exploration Ltd. is a natural resource enterprise listed on the OTCQB. The Company is concentrating on domestic and worldwide exploration and development projects. Currently, its dedication is to building cash flow from oil and gas production in central Texas and exploration for gold on the Winnemucca Mountain Property in Nevada. Northern Minerals & Exploration is based in Cisco, Texas.

The Company has completed a geological and engineering review of its first oil and gas project. Furthermore, it has outlined its work program to rework/re-complete the three wells on the J.E. Richey lease located in Coleman County, Texas to place these three wells into production. Northern Minerals & Exploration is currently evaluating other projects for potential acquisition and/or participation.

The Company announced in October 2014 that it acquired a 75 percent Working Interest (WI) in the Coleman County Lease. This is subject to a 25 percent royalty. Moreover, in April 2015, it announced that it entered into an agreement for the purchase and sale of a 37.5 percent WI in three wells on the Lease. The funds were to be advanced to Northern Minerals & Exploration as payment towards the turnkey costs of re-working and/or re-completing the three wells, and other costs associated with bringing these three wells back into production.

The Coleman County 206.5 acre lease is in a productive multiple pay area originally discovered by ARCO in the early 1980's. The lease area has six known historic productive formations. These are Ellenburger (4,200'), Gray (3,850'), Gardner (3,700'), Jennings (3,600'), Upper Capps (3,450'), and Morris (3,400').

The three wells of the Agreement are completely equipped with downhole pumps, rods, tubing, pump jacks, and also well head and surface equipment. This includes flow lines, production tanks, meter connections, and gas gathering pipelines. Subsequently, in July 2015, Northern Minerals & Exploration reported that it successfully completed the re-work and/or re-completion of three oil and gas wells on the Coleman County lease in central Texas. Moreover, the next month, the Company announced that it started commercial production on the Coleman County lease with the completion of the first sales of oil and gas.

Northern Minerals & Exploration Ltd. (NMEX), closed Tuesday's trading session at $0.0245, even for the day. The average volume for the last 60 days is 14,446 and the stock's 52-week low/high is $0.018/$0.14.

GenSpera, Inc. (GNSZ)

Gold Investment Letter reported earlier on GenSpera, Inc. (GNSZ), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

GenSpera, Inc. is a biotechnology company based in San Antonio, Texas. It conceives, designs, and develops cancer therapies. The Company’s technology platform combines a strong, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that targets the release of drugs within solid tumors without the side effects of chemotherapeutic agents. GenSpera lists on the OTC Markets’ OTCQB.

GenSpera’s technology platform supports the development of a group of drugs targeted at different cancers, and also other applications such as imaging. The Company’s lead drug candidate is mipsagargin. It was granted Orphan Drug designation by the US Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

Phase II clinical trials for lead compound mipsagargin, also known as G-202, are taking place in two indications. One is the above-mentioned liver cancer and the other is glioblastoma, or brain cancer. Mipsagargin has demonstrated positive data in a Phase 2 clinical trial in patients with hepatocellular carcinoma (liver cancer).

In January of 2015, GenSpera announced the encouraging results of a Phase II study of mipsagargin (G-202), the investigational agent for the treatment of hepatocellular carcinoma (HCC). Mipsagargin targets the enzyme prostate-specific membrane antigen (PSMA), which is highly expressed in tumor vasculature and prostate cancer cells. The Phase II results demonstrated that mipsagargin appears to be effective and is well-tolerated by HCC patients. The Phase II study results (n=25) demonstrate that the prodrug effectively stabilizes progression of HCC through decreasing blood flow within tumors while not affecting blood flow within normal tissues.

In May 2015, GenSpera announced the successful completion of the first stage of an ongoing Phase II study of its lead investigational agent, mipsagargin (G-202), in glioblastoma (brain cancer) and the continuation of enrollment for an expansion phase of the trial. The two-stage, single-arm, open-label study (NCT02067156) is led by David Piccioni, M.D., Ph.D. and Santosh Kesari, M.D., Ph.D. at the UC San Diego Moores Cancer Center in La Jolla, California. The study will evaluate the efficacy, safety, and central nervous system (CNS) exposure in patients with recurrent or progressive glioblastoma.

GenSpera’s goals for this year include the clinical development of Mipsagargin - the Phase 2 Glioblastoma (Brain Cancer) Study; the Phase 2 Prostate Cancer Study; and the Phase 2a Dose-escalation Hepatocellular Carcinoma (Liver Cancer) Study.

GenSpera previously announced a strategic partnership with Phyton Biotech for the manufacture of thapsigargin, which is the key ingredient in mipsagargin. GenSpera said that it believes that Phyton Biotech’s plant cell fermentation expertise in converting the thapsia plant into a preserved, fermentable cell line will provide GenSpera access to a sustainable source of high-quality thapsigargin to support the development of the Company’s drugs.

GenSpera, Inc. (GNSZ), closed Tuesday's trading session at $0.12375, down 6.60%, on 12,267 volume with 6 trades. The average volume for the last 60 days is 34,484 and the stock's 52-week low/high is $0.101/$0.9372.

Ironclad Performance Wear Corp. (ICPW)

Stock News Now reported recently on Ironclad Performance Wear Corp. (ICPW), Zacks and SmallCapVoice reported previously, and today we report on the Company, here at the QualityStocks Daily Newsletter.

Ironclad Performance Wear Corp. is a leader in high-performance task-specific work gloves. In 1998 it created the performance work glove category. The OTCQB-listed Company engineers and manufactures its products with a focus on innovation, design, advanced material science, and durability. Ironclad Performance Wear sells its products under the Ironclad brand.  The Company is based in El Segundo, California.

Ironclad Performance Wear continues to take advantage of its leadership position in the safety, construction, and industrial markets through the design, development and distribution of specialized task-specific gloves for varied industries. These include oil & gas extraction; automotive; and police, fire, first-responder and military.

Ironclad offers technical gloves designed for individual user groups. This includes carpenters, machinists, package handlers, plumbers, welders, roofers, oil and gas workers, mechanics, hunters, gardeners, and do-it-yourself users. Furthermore, the Company offers long and short sleeved shirts; and performance jackets, pants, shorts, reflective and polo shirts, underwear, and tights. 

Ironclad Performance Wear’s gloves and apparel are available via industrial suppliers, hardware stores, home centers, lumber yards, and sporting goods retailers throughout the United States. In addition, they are available through authorized distributors in North America, Europe, Australia and Asia.

This month, Ironclad Performance Wear reported financial results for Q1 ended March 31, 2016. It reported Net Sales for Q1 of 2016 of $5.05 million. This represents an increase of 10.5 percent from the Q1 total of $4.57 million for 2015. This increase in sales was mainly attributable to growth in its industrial and international segments.

Its Gross Profit was $1.82 million, or 36.1 percent of Net Sales in Q1 of 2016, versus $1.77 million, or 38.7 percent of Net Sales in Q1 of 2015.  This decrease in the Gross Margin percentage is chiefly attributable to start-up costs in relation to the new Grainger program.

Ironclad’s Loss from Operations in Q1 of 2016 was $323,000, or (6.4 percent) of Net Sales, versus a loss of $84,000, or (1.8 percent) of Net Sales, during the same period the year prior. Its Net Loss for Q1 of 2016 was $358,000, or $0.00 per share, versus a loss of $99,000, or $0.00 per share, in the same period in 2015.

Ironclad Performance Wear Corp. (ICPW), closed Tuesday's trading session at $0.24, up 6.67%, on 16,500 volume with 5 trades. The average volume for the last 60 days is 24,356 and the stock's 52-week low/high is $0.212/$0.3275.

CanAlaska Uranium Ltd. (CVVUF)

OTC Markets Group and FeedBlitz reported previously on CanAlaska Uranium Ltd. (CVVUF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CanAlaska Uranium Ltd. is an exploration stage enterprise headquartered in Vancouver, British Columbia. The Company focuses on two key projects in the Athabasca Basin in the Province of Saskatchewan. Founded in 1985, the Company previously went by the name CanAlaska Ventures Ltd. It changed its name to CanAlaska Uranium Ltd. in October of 2006. Its shares trade on the OTC Bulletin Board.

CanAlaska Uranium is a project generator. The Company says it’s positioned for discovery success in the world's richest uranium district. CanAlaska Uranium holds interests in around 700,000 hectares (1.7 million acres), one of the largest land positions in the Athabasca Basin. Its strategic holdings have attracted major global mining companies Cameco, KORES and KEPCO as partners at its core projects.

CanAlaska Uranium’s projects include Cree East, West McArthur, NW Manitoba, as well as other uranium projects and its diamond projects. The Cree East project is a high-priority property situated in the south-eastern portion of the Athabasca Basin. The project consists of 16 contiguous mineral claims totaling 55,935 ha.

The West McArthur project is contiguous to the world’s richest uranium mine - Cameco's McArthur River. The goal at West McArthur is a large unconformity uranium deposit.  Moreover, $20 million of work successfully identified seven target areas. They are presently undergoing evaluation and the priority targets are on grid 5 and grid 1.

Furthermore, The NW Manitoba project lies in northwest Manitoba just east of the border of northeast Saskatchewan. It is 70 kilometers north of Reindeer Lake and encompasses 143,603 hectares.

Last month, CanAlaska Uranium announced that it reached an Agreement to sell one of its three Waterbury claims to Cameco Corp. (CCJ). The sales agreement for the Waterbury West claims is for cash consideration of $71,732, a commitment for a program of work to drill at least one hole on the project targets within 3 years, and a 2 percent uranium royalty on future production.

The Waterbury East and South claims remain 100 percent owned by CanAlaska Uranium. The Waterbury West property is 3,764 hectares in size. It is situated over the central portion of Waterbury Lake, immediately north east of the Cigar Lake mine.

CanAlaska Uranium Ltd. (CVVUF), closed Tuesday's trading session at $0.459, down 2.34%, on 26,300 volume with 15 trades. The average volume for the last 60 days is 35,296 and the stock's 52-week low/high is $0.0603/$0.5022.

CIB Marine Bancshares, Inc. (CIBH)

Stock Traders Chat reported previously on CIB Marine Bancshares, Inc. (CIBH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CIB Marine Bancshares, Inc. operates as the bank holding company for CIBM Bank, which provides banking and related services to small and middle-market business customers. Incorporated in 1985, CIB Marine Bancshares has its corporate headquarters in Waukesha, Wisconsin. It has offices in the Central and Northeastern Illinois, Milwaukee, and Indianapolis markets. Its shares trade on the OTC Markets Group’s OTCQB.

CIBM Bank operates as Marine Bank in its Indiana and Wisconsin markets, Central Illinois Bank in its central Illinois market, and Avenue Bank in its Chicagoland market. Located in Naperville, Illinois, the Avenue Mortgage division of the Bank serves all CIBM Bank markets. The Company operates via Banking and Mortgage Banking segments. It accepts demand, savings, and time deposits.

The traditional banking services that CIBM Bank offers includes a wide array of loan products, including commercial loans, commercial real estate loans, commercial and residential construction loans, one-to-four family residential real estate loans, consumer loans, and commercial and standby letters of credit. Services offered also include acceptance of demand, savings and time deposits; commercial paper and repurchase agreements; as well as other banking services.

Recently, CIBM Bank reported that Ms. Bridget Condon has joined CIBM Bank, as a Vice President of Commercial Banking/Small Business Lending. She is reporting to the Director of Corporate Banking, Mr. James Mullaney. Based in the Milwaukee area, Ms. Condone will concentrate on commercial and SBA lending opportunities in the Bank's Wisconsin, Illinois, and Indianapolis markets. She has 14 years of experience in banking. This includes roles at Wisconsin Bank and Trust, BMO Harris, and Community Bank and Trust.

Last month, CIB Marine Bancshares announced its results of operations and financial condition for Q1 of 2016. Net Income for Q1 was $952,000 or $0.05 per share. This is in comparison to a loss of $795,000 or $0.04 per share for Q4 of 2015 and Net Income of $26,000 or $0.00 per share for Q1 of 2015.

For Q1 2016, the Net Income for subsidiary CIBM Bank was $662,000. This reflects robust improvements in net interest income and non-interest income because of the growth in loans and a growing mortgage division.

CIB Marine Bancshares, Inc. (CIBH), closed Tuesday's trading session at $0.65, up 12.07%, on 6,000 volume with 5 trades. The average volume for the last 60 days is 8,846 and the stock's 52-week low/high is $0.27/$0.58.

graphic

The QualityStocks
Company Corner

graphic
graphic

Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0112, up 1.82%, on 1,552,623 volume with 38 trades. The stock’s average daily volume over the past 60 days is 2,382,159 and its 52-week low/high is $0.0035/$0.339.

Dominovas Energy Corp. today announces the appointment of Mr. Mansur Nuruddin, Esq. as advisor, as well as the engagement of his Johannesburg-based firm, MNCapital Africa Advisors (www.mncapital-africa.com). Mr. Nuruddin will assume responsibility for Dominovas Energy's capital raising, project financing, capital markets, and advisory activities, as well as advising the Company on specific issues relating to corporate governance, corporate finance, and investor relations. Mr. Nuruddin will report to Neal Allen, chairman and chief executive officer of Dominovas Energy.

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Welcomes Project Finance Team

Dominovas Energy Launches New Hydropower Division Currentergy

Dominovas Energy Launches the First Rubicon SOFC Project in South Africa

Monaker Group, Inc. (MKGI)

The QualityStocks Daily Newsletter would like to spotlight Monaker Group, Inc. (MKGI). Today, Monaker Group, Inc. closed trading at $2.10, up 10.53%, on 935 volume with 5 trades. The stock’s average daily volume over the past 60 days is 6,205, and its 52-week low/high is $1.10/$9.99.

Monaker Group, Inc. (MKGI) is a technology driven travel company focused on leveraging resources to become a significant presence in the fastest growing sector of the $1.3 trillion travel and tourism market. The company's flagship brand, NextTrip.com, is the industry's first and only real-time booking engine that features alternative lodging (vacation home rentals, resort residences and unused timeshare inventory), as well as a full selection of airlines, hotels, cruises, rental cars, tours and concierge services. These features are combined into a single, easy-to-use platform that gives travelers complete real-time control when planning and booking their vacations.

NextTrip.com takes an integrated approach to the needs of travelers by combining multiple booking solutions into a highly intuitive real-time booking platform. Since its launch in February 2016, NextTrip has already grown to more than 250,000 units of vacation rental inventory. Monaker currently has roughly 1 million additional alternative lodging units under contract that will soon be added to the platform. This will place NextTrip among the top three largest vacation rental inventories and rival industry peers, Airbnb and HomeAway, in the rapidly expanding alternative lodging market. Unlike the competition, which book by request which can take hours or days before a lodging owner confirms, NextTrip's platform books in real-time, similar to online hotel bookings.

Most NextTrip listings are in desirable locations in the U.S., the EU and the Caribbean with about 20% exclusive listings. Monaker expects rapid exclusive listing growth because, unlike the competition, Monaker doesn't charge a sign-up fee, just a commission upon booking. The competition charges both. Monaker even has a proprietary solution to unlock Timeshare and Fractional Share properties as rental inventory.

Through strategic partnerships and acquisitions Monaker is now positioned to be a major player in the travel and alternative lodging sector. In addition Monaker is also the parent to Maupintour and Voyage TV.

In business for 65 years, Maupintour still leads the tour industry in the creation of outstanding, unique itineraries and has the highest repeat rate in the tour industry. Maupintour's upscale luxury services create a unique blend with the various product offerings of NextTrip. Voyage TV has thousands of hours of travel footage shot in over 30 countries worldwide. These 15,000 video clips of hotels, resorts, cruise, and destination activities are a treasure trove for vacation travel marketing.

With an established portfolio of travel brands, and a proven record acquiring, consolidating and integrating companies, Monaker is building a diverse and exciting foundation to drive the company's future. According to data from the U.S. Travel Association, direct spending on leisure travel by domestic and international travelers topped $650 billion in 2015. When combined with the fact that roughly 64 percent of travel companies are still considered small businesses, Monaker's all-inclusive approach to vacation booking through NextTrip and Maupintour strategically positions it for sustainable growth moving forward.

Monaker is headquartered in South Florida with offices in California. The company is led by a seasoned management team with decades of applicable industry experience. Monaker's Chairman and Chief Executive Officer Bill Kerby has over 18 years of experience in the media and travel industries, as well as 10 years of experience in the financial industry. Disclaimer

Monaker Group, Inc. Company Blog

Monaker Group, Inc. News:

MissionIR Exclusive Audio Interview With Monaker Group, Inc. (MKGI) Chief Executive Officer

Monaker Group, Inc. (MKGI) Announces Engagement of DreamTeamNetwork Corporate Communications Service Suite

Monaker Groups Booking Technology Unlocks Specialty Lodging Inventory

Alternet Systems, Inc. (ALYI)

The QualityStocks Daily Newsletter would like to spotlight Alternet Systems, Inc. (ALYI). Today, Alternet Systems, Inc. closed trading at $0.009, up 1.12%, on 50,500 volume with 2 trades. The stock’s average daily volume over the past 60 days is 129,362, and its 52-week low/high is $0.0036/$0.029.

Alternet Systems, Inc. (ALYI) invests in and partners with companies that are creating the future of money in the high growth, emerging technology fields of digital commerce, multichannel payments, and predictive analytics.

Vision: Be the leading digital commerce, multichannel payments, predictive analytics solutions provider into global markets

Mission: To provide innovative solutions that facilitates and expedites commerce, enriching our partners and their customers' experience, and improving efficiency. Recognizing that the world is becoming increasingly dependent on technological conveniences, Alternet Systems aims to provide its customers with the tools to prepare themselves for a new era of digital commerce and payments, financial services and consumer information, and, most importantly, a new era of how to live.

Since 2010, Alternet has maintained a progressive focus on the high-growth, mobile value-added service industries of mobile financial services and mobile security. In 2014, the company expanded its scope of expertise to include in its investment verticals the exciting digital commerce space, transforming the legacy electronic payments infrastructure and developing advanced predictive data analytics applications for the mass consumer, telecommunications and financial industry.

With strategic investments in these three key, high-growth markets, Alternet is accelerating the future of money and its role in the global demand for these services. The company is guided by a team of executives specializing in entrepreneurial endeavors, innovation, corporate strategy, financial and executive management of multi-national organizations, and a vast network of industry resources.

As Alternet embarks on this new path, the company will be led by a management team and board of directors with over a century's worth of combined experience in the fields of investing, technology, and financing, and the consensus knowledge of where to invest and when in start-up and early-stage companies. Disclaimer

Alternet Systems, Inc. Company Blog

Alternet Systems, Inc. News:

Alternet Systems Data Analytics Solution Gains Momentum with New Clients and Partners

Alternet Systems Announces Caprock Research Report with Near Term Price Target of $0.05 and 'Accumulate' Recommendation

Alternet Systems Launches Data Analytics Division To Build On Existing Revenue Base

International Stem Cell Corp. (ISCO)

The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $2.30, up 4.55%, on 5,456 volume with 25 trades. The stock’s average daily volume over the past 60 days is 7,423, and its 52-week low/high is $1.25/$7.50.

International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.

The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.

The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.

In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer

International Stem Cell Corp. Company Blog

International Stem Cell Corp. News:

Cryoport to Provide Cold Chain Logistics Support for International Stem Cell Corporation's Phase I Clinical Trial for the Treatment of Parkinson's Disease

International Stem Cell Corporation Announces Operating Results for the Three-Months Ended March 31, 2016

International Stem Cell Corporation Announces 2015 Fourth Quarter and Year-End Results

Cherubim Interests, Inc. (CHIT)

The QualityStocks Daily Newsletter would like to spotlight Cherubim Interests, Inc. (CHIT). Today, Cherubim Interests, Inc. closed trading at $0.0001, even with yesterday's close. The stock’s average daily volume over the past 60 days is 1,479,340, and its 52-week low/high is $0.0001/$0.1575.

Cherubim Interests, Inc. (CHIT) is a development-stage alternative construction and real estate development company seeking various opportunities relative to the company's management team of experts in property management, construction and finance.

The company's primary focus is within the real estate development and controlled environment agriculture sectors, which Cherubim recently entered into by acquiring an exclusive worldwide license for the deployment of a proprietary plant cultivation technology. Through its wholly owned subsidiary, BudCube Cultivation Systems USA, Cherubim plans to construct, deploy and lease scalable medical and recreational marijuana cultivation facilities for commercial applications.

Coupled with a real estate development and property management business model, BudCube Cultivation Systems ("BCS") can position itself anywhere in the world where the cultivation of cannabis is legal. BCS's unique business model positions the company to greatly benefit as more market participants seek to gain entry into a fast-growing market at an attractive price point.

Armed with the ability to lease a portable and scalable turn-key cultivation solution to growers, Cherubim aims to use its licensed solution to fill the gap for both first-time and experienced cultivators who may not have the capital resources to buy land, construct or tenant-improve existing structures for the optimum environment for developing a high-quality cannabis product. Disclaimer

Cherubim Interests, Inc. Company Blog

Cherubim Interests, Inc. News:

Moving Ahead of Averages, Technical Review -- Research on Saleen Automotive, Cherubim Interests, Fission Uranium, and Pure Biosciences

Cherubim Interests, Inc. Signs MOU to Acquire Revenue-Producing Company

Cherubim Interests Inc. Announces FINRA Approval of Convertible Preferred Stock Dividend

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

MarketClub Analysis
(SPEX)

2.

MissionIR
(CNCK)

3.

QualityStocks
(AERT)

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251